Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

Name: Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
Published: 2004
License: Public Domain

National Cancer Institute (NCI) · 2004

ClinicalTrials.gov · Datasets · License: Public Domain · 2004

Open Source ↗

brenner tumor, fallopian tube cancer, ovarian clear cell cystadenocarcinoma, ovarian endometrioid adenocarcinoma, ovarian mixed epithelial carcinoma, ovarian mucinous cystadenocarcinoma, ovarian serous cystadenocarcinoma, ovarian undifferentiated adenocarcinoma, primary peritoneal cavity cancer, stage ii ovarian epithelial cancer, stage iii ovarian epithelial cancer, stage iv ovarian epithelial cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 900808
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.